Primary data · sourced from public filings·700+ listed companies · India-first·
Open screener
ἀλήθεια · aletheiaAncient Greek for truth — literally “un-forgetting”: the act of revealing reality, not merely stating it
← All posts
Sector Thesis·4 min read·Week 26

Painkillers Beat Vitamins Every Time: YC's Brutal Test

YC rejects 99% of vitamin ideas. Painkillers solve acute, recurring problems that bleed money. Learn to reframe your startup as essential, not optional—with frameworks and India-specific examples.

ByAmit Tyagi·Fitoor Capital
Aletheia Insights · Weekly

Get 1 unfair insight every week from India's startup ecosystem.

Read by serious founders and investors. No fluff.

The Unit Economics Reveal Everything

Paul Graham wrote: "The threshold for investment is whether the founders want it enough." That's vague. Here's the metric: Would your customer pay 30% of revenue to solve this?

Payroll software (painkiller) hits 15-25% of monthly payroll spend. CRM tools fight for 2-5%. Why? Because not paying salaries kills your business in 24 hours. CRM features delay decisions by weeks.

This isn't moral judgment. It's survival math.

Indian founders often build vitamins disguised as painkillers. Fintech onboarding tools. Recruitment filters. Analytics dashboards. Nice problems, but not acute. Customers have 47 workarounds before they call you.

The Painkiller Test Framework

Before writing code, run this:

Question 1: Does the problem recur daily or weekly?
Vitamins recur monthly or never. Painkillers interrupt work every shift.

Question 2: Does it directly cost money when unsolved?
Payroll delays = penalty + staff rage. Missing candidate emails = hiring takes 30 days longer. But delayed hiring doesn't cost money in hour one. It bleeds over 8-12 weeks.

This is why recruitment tools underperform unless they solve candidate ghosting or offer acceptance prediction—immediate, measurable problems.

Question 3: Would customers build it themselves if you disappeared?
If yes, you're solving a real painkiller. (See: early Notion customers building databases in Airtable.)

If they'd switch to Excel or process drift, you're a vitamin.

India-Specific Pattern: The B2B Vitamin Trap

Indian SaaS founders are obsessed with enterprise features: audit logs, SSO, role-based permissions. These look essential. They're not.

They're vitamins bundled with the aspirin.

A D2C logistics player in Bangalore doesn't pay for SSO first. They pay for same-day rate visibility. A mid-market payroll company doesn't need audit logs. They need compliance with 23 state labor rules.

When Dukaan.io launched, they didn't lead with "beautiful analytics dashboard." They led with "sell offline inventory online in 30 minutes." Same pain, solved first.

Ask: What problem kills their day if unsolved? Build that. Everything else is moat-building, not product-market fit.

The Positioning Hack (From Scott Belsky)

Here's a non-obvious move: The same product can be painkiller or vitamin depending on positioning.

Slack isn't a chat tool. It's a "replace 47 meeting requests per week." Now it's a painkiller.

Notion isn't a doc tool. It's "replace 8 different tools your team bought with personal credit cards." Painkiller framing.

Asana isn't a project tracker. It's "prevent your CEO from asking 'where are we on Project X?' 14 times per day." Acute pain.

Your product doesn't change. Your positioning does.

For Indian founders: Don't say "AI-powered supply chain optimization." Say "reduce stockout penalties by Rs. 8 lakhs/month guaranteed or no payment." That's painkiller positioning.

Vitamin Graveyard: Why They Fail

Vitamins suffer from:

1. Flat or declining retention. Users love you for 4 weeks. Then: "nice, but not critical." Churn hits 60% by month six.

2. Sales friction. Every deal requires justification to finance. Painkillers justify themselves: "This saves Rs. 12 lakh/month."

3. Distribution ceiling. Vitamins max out at 20-30% of addressable market. Painkillers often exceed 60%.

4. Low pricing power. You're competing on features, not survival. Race to bottom begins.

Checklist Labs (scheduling tool) was a vitamin. They peaked at 200 customers. Calendly (also scheduling, but positioned as "stop sending 8 follow-up emails") hit 10M users. Same problem category. Opposite positioning.

The Non-Obvious Insight

Most failed startups weren't founded on bad problems. They were founded on real problems that weren't acute enough.

Everyone wants better expense reporting. Almost no one will switch tools for it. But preventing tax audits? Acute.

Every CFO wants better cash forecasting. But preventing a Rs. 2 crore surprise shortfall? That's painkiller.

Your hypothesis isn't wrong. Your positioning is.

The Reframe

Before pitching or raising, ask investors: "If we shut down tomorrow, would your team have a crisis?"

If the answer is "we'd go back to X," you're a vitamin.

If it's "we'd have a real problem," you're a painkiller.

Reposition or retarget. Don't launch yet.

Actionable Move Today

Interview your top 5 customers. Ask: "What would happen to your business if this broke tomorrow?"

If the answer involves money or time loss in hour one, you're painkiller-positioned.

If it's "we'd manage" or "we'd use Excel," you're vitamin-positioned. Either fix the framing or solve a sharper problem.

Unit economics don't lie. Your customers' urgency reveals everything.

Amit Tyagi

Founder, AletheiaAI & GP, Fitoor Capital

Veteran of India's startup ecosystem. Writing about fundraising, investor psychology, and what it takes to build fundable startups in India.

Run a fundability check

India's only MRE-backed platform for founders and investors. Analyse your deck, find investors, and validate your raise strategy.

#idea-validation#problem-selection#yc-advice#startup-strategy

Don’t miss the next one

One insight every week. No fluff.

Aletheia Insights · Weekly

One contrarian insight. Every week. No generic startup advice.

Join founders and investors building with better information.

Painkillers Beat Vitamins Every Time: YC's Brutal Test · Aletheia Insights